A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2001
10/23/2001	US6306879 Isotonic glucose solution
10/23/2001	US6306878 Pharmaceutical compositions containing hydroximic acid derivatives
10/23/2001	US6306877 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
10/23/2001	US6306876 4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives
10/23/2001	US6306875 Growth-hormone secretagogues
10/23/2001	US6306874 Enzyme inhibitors such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
10/23/2001	US6306873 Substituted β-thiocarboxylic acids
10/23/2001	US6306872 6-substituted 1,2,4a,5a,8a,8b-hexahydro- and 1,2,3,4,4a,5a,8a,8b-octahydro-6H-pyrrolo[3′,4′:4,5]furo[3,2-b]pyrid-8(7H)-one derivatives and their use in combatting endoparasites
10/23/2001	US6306871 Iodonitrobenzamide derivatives as anticarcinogenic, antitumor agents and viricides
10/23/2001	US6306870 N-cinnamoyl derivatives of beta-carboline
10/23/2001	US6306869 N-oxides
10/23/2001	US6306868 Methods for inhibiting the growth of tumors with 7-substituted camptothecin derivatives
10/23/2001	US6306867 Treatment of respiratory system disorders, tumor necrosis factor and leukotrienes
10/23/2001	US6306865 Pharmaceutically active benzoquinazoline compounds
10/23/2001	US6306864 Cerebral deficits subsequent to or resulting from cardiac bypass surgery and grafting, stroke, cerebral ischemia, spinal cord trauma, head trauma
10/23/2001	US6306863 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
10/23/2001	US6306862 Treatment of liver disorders
10/23/2001	US6306858 Antiinflammatory agents for muscle inflammation by appling to skin
10/23/2001	US6306857 Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanones
10/23/2001	US6306856 Dissolving pyridonecarboxylic acid or salt, mixing with glycyrrhizic acid with acid
10/23/2001	US6306854 Chemical compounds
10/23/2001	US6306852 Indole derivatives useful as endothelin receptor antagonists
10/23/2001	US6306851 Cyclocarbamate and cyclic amide derivatives
10/23/2001	US6306850 Chlorocyclopropyl-3-(2-chlorophenyl)-2-hydroxypropyl)2,4-dihyd ro-(1,2,4)-triazole-3-thione as fungicides
10/23/2001	US6306849 Selected derivatives of K-252a
10/23/2001	US6306848 Skin treatment
10/23/2001	US6306846 Anti-inflammatory and anti-ulcer compounds and process
10/23/2001	US6306845 Steroid derivatives for nervous system disorders
10/23/2001	US6306844 Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength
10/23/2001	US6306841 Treatment of female sexual dysfunction
10/23/2001	US6306840 Cell adhesion inhibitors
10/23/2001	US6306838 Targeted vesicular constructs for cyto protection and treatment of h. pylori
10/23/2001	US6306836 Peritoneal dialysis solutions containing maltodextrins and amino acids
10/23/2001	US6306835 Biocidal chitosan derivatives
10/23/2001	US6306833 Methods and compositions for inducing tumor-specific cytotoxicity
10/23/2001	US6306831 Transplacental delivery of oligonucleotides
10/23/2001	US6306828 Enantiomerically-enhanced nutritional energy substrates
10/23/2001	US6306822 Phosphopeptides and methods of treating bone diseases
10/23/2001	US6306820 Combination therapy using a TNF binding protein for treating TNF-mediated diseases
10/23/2001	US6306819 Method for regulating size of vascularized normal tissue
10/23/2001	US6306789 Mucoadhesive granules of carbomer suitable for oral administration of drugs
10/23/2001	US6306655 Antisense inhibition of C/EBP alpha expression
10/23/2001	US6306651 Bone marrow hematopoietic stem cell; for use in prevention of graft versus host disease
10/23/2001	US6306613 Modulators of leaderless protein export and methods for identifying and using the same
10/23/2001	US6306595 Design of drugs involving receptor-ligand-DNA interactions
10/23/2001	US6306453 Anti-stress agents for aquatic animals
10/23/2001	US6306438 For therapy of pain; storgae stability
10/23/2001	US6306437 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
10/23/2001	US6306436 Stabilized, acid-free formulation for sustained release of bupropion hydrochloride
10/23/2001	US6306431 Dermal drug delivery system
10/23/2001	US6306430 Process for decreasing adiposity using vitamin a as a dietary supplement
10/23/2001	US6306429 Throat drops suitable for relief of cough and cold symptoms
10/23/2001	US6306426 Implant device with a retinoid for improved biocompatibility
10/23/2001	US6306425 Time release agents; therapy of drug abuse and drug dependence
10/23/2001	US6306423 Biocompatible implant for continuous in vivo release of a neurotoxin over a treatment period extending from one month to five years
10/23/2001	US6306421 Therapeutic inhibitor of vascular smooth muscle cells
10/23/2001	US6306393 Administering to subject having a b-cell related malignancy a therapeutic composition comprising a pharmaceutically acceptable carrier and a combination of at least one naked anti-cd19 antibody and an anfi-cd20 antibody
10/23/2001	US6306392 Prevention and/or treatment of alterations of those organs which perform metabolic function, such as liver, kidneys, cardiovascular system and brain; for therapy of hepatosis, nephropathies and cardiovascular or cerebral damage damage
10/23/2001	US6306388 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
10/23/2001	US6306384 Skin battery cosmetic composition
10/23/2001	US6306383 Method for topical treatment of scars with protein kinase C inhibitors
10/23/2001	US6306369 Comprising bronchodilatory agent, anti-infalmmatory agent and 1,1,1,2-tetrafluoroethane propellent; for administration of medicaments by inhalation; for therapy of respiratory system disorders
10/23/2001	CA2302963C Soft gelatin capsule manufacture
10/23/2001	CA2236368C Sublingual and buccal administration of selegiline
10/23/2001	CA2222657C Intermediates in preparation of new phenylethanolaminomethyltetralins
10/23/2001	CA2211284C Multiple unit sustained release dosage form
10/23/2001	CA2203566C Percutaneously administration preparation
10/23/2001	CA2203310C Compressed matrix for slow release of salt of tianeptine sodium following oral administration
10/23/2001	CA2108064C Thiazolidine dione compounds, process for preparing same and pharmaceutical compositions containing same
10/23/2001	CA2107150C Chromenic derivatives having a triene lateral chain, process for the preparation thereof and pharmaceutical compositions containing them
10/23/2001	CA2096346C Combinations of anthelmintically active agents
10/23/2001	CA2087606C (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same
10/23/2001	CA2085570C Pyrrolidine derivatives, process for their preparation and pharmaceutical compositions containing them
10/23/2001	CA2083179C Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
10/23/2001	CA2080343C 5-benzyl barbiturate derivatives
10/23/2001	CA2079342C Multi-functional pharmaceutical compounds and methods of use
10/23/2001	CA2079189C (benzocycloalkyl) alkylamines, their preparation process and pharmaceutical compositions containing them
10/23/2001	CA2049368C Treatment of cerebro-vascular disorders
10/23/2001	CA2047496C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
10/23/2001	CA2043625C Skin preparations for external use
10/23/2001	CA2040058C Alpha-mannosidase and fucosidase inhibitors
10/23/2001	CA2037411C Milbemycin ether derivatives
10/23/2001	CA2035749C Pyrroloazepine derivatives
10/23/2001	CA2035499C Substituted triazolopyridazines
10/23/2001	CA2035397C Hexahydropyrrolo¬2,3-b\|indole carbamates, -ureas, -amides and related compounds, a process for their preparation and their use as medicaments
10/23/2001	CA2032772C 2-formylbenzylphosphonic acid derivatives, their preparation and their use for the treatment of diseases caused by viruses
10/23/2001	CA2023404C Phosphorylated glycosidase inhibitor prodrugs
10/23/2001	CA1341308C Vaccines against avian herpes viruses
10/23/2001	CA1341307C Nucleotide sequences of avian herpes viruses
10/18/2001	WO2001077378A2 Diagnosis of diseases associated with dna adducts
10/18/2001	WO2001077377A2 Diagnosis of diseases associated with dna replication by assessing dna methylation
10/18/2001	WO2001077376A2 Diagnosis of diseases associated with metastasis
10/18/2001	WO2001077375A2 Diagnosis of diseases associated with gene regulation
10/18/2001	WO2001077371A1 Preincubation assay method
10/18/2001	WO2001077360A2 Methods for ansamitocin production
10/18/2001	WO2001077357A2 Chromosomal vectors and uses thereof
10/18/2001	WO2001077322A1 Cryptic-like secreted protein
10/18/2001	WO2001077295A1 Mutant bank
10/18/2001	WO2001077294A2 Hpv-specific short-mers
10/18/2001	WO2001077164A2 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis

1 ... 5986 5987 5988 5989 5990 5991 5992 5993 5994 5995 5996 5997 5998 5999 6000 6001 6002 6003 6004 6005 6006 ... 7860